Kitchener, ON – November 12, 2021 – Intellijoint Surgical is excited to announce that Intellijoint VIEW™ has been granted 510(k) clearance by the FDA and is now available for sale and use in the United States. Intellijoint VIEW, which was licensed by Health Canada in August, is a surgical planning solution that provides targets for functional cup position accounting for the hip-spine relationship and implant templating to generate targets for leg length inequality and offset restoration without requiring CT imaging. VIEW integrates seamlessly with the Intellijoint HIP® navigation system, allowing surgeons to access and deliver their plans intraoperatively.
Intellijoint Surgical is attending the American Association of Hip and Knee Surgeons Annual Meeting from November 11-13th in Dallas, TX to showcase the new product for the first time with live product demonstrations of the complete Intellijoint ecosystem of products supporting the entire episode of care.
Intellijoint VIEW can be used by clinicians to assess a patient’s spinopelvic mobility with a new feature called the Target Zone Visualizer™ (TZV) to provide a functional acetabular cup target that is unique to each patient. The feature allows analysis of x-ray images of a patient in both sitting and standing positions and the application of the novel hip-spine relationship concepts to produce a cup target. VIEW can assist surgeons in identifying at-risk patients for adverse spinopelvic mobility conditions, such as ‘stuck-standing’ or ‘stuck-sitting’ postures, and with the TZV feature, help plan a patient-specific cup position to accommodate their mobility to help reduce the chance of impingement or dislocation. VIEW also enables implant templating, identifying leg length inequality, and offset restoration needs for optimal implant sizing and selection.
About Intellijoint Surgical
Intellijoint Surgical® develops and commercializes surgical planning & navigation solutions for total hip and knee joint replacements, as well as digital patient engagement for all orthopaedic specialties. It is committed to improving patients’ lives by providing every surgeon with effective, easy-to-use technology to manage the entire episode of care. Intellijoint’s technology is used by top orthopaedic institutions and surgeons globally. For more information on Intellijoint Surgical visit www.intellijointsurgical.com. For more information on Intellijoint VIEW visit: www.intellijointsurgical.com/VIEW/
Lisa Kawalez, Marketing Manager